Blue Light Therapy for Liver Surgery
NCT02915081 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2019-04-05
Summary
The investigators hypothesize that subjects undergoing liver resection and who are exposed preoperatively to high illuminance blue spectrum light will exhibit reduced organ injury, specifically liver dysfunction, than subjects exposed to standard ambient white fluorescent light.
Conditions
- Acute Kidney Injury
- Liver Injury
- Inflammation
Interventions
- OTHER
-
Blue light
Illumination: High illumination lighting will be instituted with a Day\*Light Classic Light (Uplift Technologies, Dartmouth, NS) Blue wavelength: Each subject will be fitted with blue filtered goggles (Lee Filters, Burbank, CA). These goggles ensure the transmission of a bright (1700 lux) blue (peak 442 nm) spectrum light when the subject is within 12 inches. Photoperiod: A 24-hour photoperiod will be used that commences at 0800 the morning prior to surgery and continues for 24 hours. To account for potential variability in the exposure of interest, each subject will complete a diary to catalogue duration and distance of light exposure. Postoperatively the same photoperiod will be instituted and continued for one 24 hour period.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
University of Pittsburgh Medical Center
collaborator OTHER -
University of Pittsburgh
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
NCT01079104 ·Status: TERMINATED ·Phase: NA
-
Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant
NCT01328132 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
NCT01548690 ·Status: COMPLETED ·Phase: PHASE2
-
Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation
NCT03563404 ·Status: COMPLETED
-
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
NCT02366845 ·Status: COMPLETED ·Phase: PHASE4
-
Does Terlipressin Improve Renal Outcome After Liver Surgery
NCT02368249 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dynamic Liver Tests in Liver Disease
NCT02782247 ·Status: COMPLETED
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures
NCT02990273 ·Status: TERMINATED ·Phase: NA
-
Biomarkers in Liver Failure
NCT02833064 ·Status: ACTIVE_NOT_RECRUITING
-
Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients
NCT02271295 ·Status: SUSPENDED ·Phase: PHASE3
-
Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
NCT07004387 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units
NCT01079091 ·Status: TERMINATED ·Phase: NA
-
Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery
NCT01435421 ·Status: UNKNOWN
-
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312 ·Status: COMPLETED
-
Liver Protection of RIPC in Pediatric Living Donor Liver Transplantation
NCT02830841 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
NCT00287664 ·Status: SUSPENDED ·Phase: PHASE4
-
Hepatocyte Transplantation as a Life Support Bridge
NCT00282542 ·Status: WITHDRAWN ·Phase: NA
-
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography
NCT02757170 ·Status: UNKNOWN ·Phase: PHASE4
-
Adult Stem Cell Therapy in Liver Insufficiency
NCT00147043 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation
NCT06149026 ·Status: RECRUITING ·Phase: NA
-
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
NCT02258048 ·Status: WITHDRAWN
-
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
NCT03130127 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of in Vivo Splitting Technique in Adult Liver Transplantation
NCT06925828 ·Status: ACTIVE_NOT_RECRUITING
-
ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF
NCT07329036 ·Status: RECRUITING ·Phase: NA